
==== Front
BMC Oral Health
BMC Oral Health
BMC Oral Health
1472-6831
BioMed Central London

39294639
4835
10.1186/s12903-024-04835-0
Research
The role of erythropoietin-loaded hydrogel versus adipose derived stem cell secretome in the regeneration of tongue defects
http://orcid.org/0000-0001-8577-4301
El-Qashty Rana Dr_Rana_Nagah@mans.edu.eg

1
http://orcid.org/0000-0002-0987-8616
Youssef Jilan 2
http://orcid.org/0000-0003-0816-1928
Hany Eman 1
1 https://ror.org/01k8vtd75 grid.10251.37 0000 0001 0342 6662 Oral Biology department, Faculty of Dentistry, Mansoura University, Mansoura, Egypt
2 https://ror.org/01k8vtd75 grid.10251.37 0000 0001 0342 6662 Periodontology, Diagnosis and Oral Radiology Department, Faculty of Dentistry, Oral Medicine, Mansoura University, Mansoura, Egypt
18 9 2024
18 9 2024
2024
24 11098 7 2024
29 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Background

Tongue defects have several etiologies and significantly affect the quality of life. This study was conducted to compare the regenerative potential of erythropoietin (EPO)-loaded hydrogel and adipose derived stem cell (ADSC) secretome on tongue dorsum defects focusing on the role of anti-inflammatory M2 macrophage phenotype.

Methods

Rats were subjected to induction of mechanical circular defects on the dorsal surface of the tongue, then divided into three groups; Group I (control): received 0.1 ml phosphate buffered saline, Group II (EPO): received 5000 U/kg EPO-hydrogel, and Group III (ADSC-Secretome): received 0.1 ml ADSC-Secretome. Treatments were injected circumferentially around wound margins after induction. Seven and fourteen days after treatment, specimens were obtained and processed for histological and immunohistochemical staining followed by the relevant histomorphometric and statistical analyses.

Results

Seven days after treatment, groups II and III presented defects with some epithelial regeneration at the lateral margins, while the center of the defect showed granulation tissue with much inflammatory cells. The base of the defects showed some muscle fibers and new blood vessels, however group III showed more enhanced neovascularization. Fourteen days after therapeutic intervention, group II defects were completely covered with epithelium showing a thin keratin layer with regular rete pegs interdigitating with the underlying connective tissue papillae, but tongue papillae were not restored. Group III expressed much better healing with developing filiform papillae. The connective tissue showed more vascularity and well-arranged muscle bundles. Both treated groups showed a significant decrease in defect depth and significant increase in anti-inflammatory macrophages compared to the control group at both time intervals, however there was no significant difference between the two treated groups.

Conclusion

Both treatments showed promising and comparable results in the treatment of tongue defects reducing inflammation and restoring tongue histological architecture with significant upregulation of M2 macrophage.

Keywords

Tongue diseases
Inflammation
Adipose tissue
Mesenchymal stem cells
Conditioned media
Anti-inflammatory M2 macrophage
CD163
Mansoura UniversityOpen access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).

issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2024
==== Body
pmcBackground

The tongue is a strong muscular organ comprised of an external mucosal membrane formed of stratified squamous epithelium with numerous lingual papillae carrying taste buds, and overlying an ecto-mesenchymal connective tissue, surrounding a combination of intrinsic and extrinsic striated muscles [1]. Tongue defects can result from several etiological factors including trauma, recurrent ulcers, and surgical excision of the diseased tissue [2] such as erythroplakia, squamous cell carcinoma, granular cell tumor, and kaposi sarcoma that significantly complicate speech, swallowing, and respiration [3, 4]. Up till now, there has been no specific treatment that thoroughly restores the anatomy and function of the tongue in patients suffering from tongue defects.

Hydrogels represent a widely used drug-delivery system. They are biological materials manufactured through a physico-chemical monomer crosslinking reaction, forming a polymer network structure [5]. They have numerous advantages including ease of preparation and use, minimal toxicity, and low cost [6]. More specifically, thermosensitive and injectable hydrogels have the capability to fill up the minute tissue spaces simply by injecting the pre-gel solution. They can encapsulate medications, cells, inorganic minerals and other therapies transmitting them to the targeted site, providing a long-lasting release and effective drug delivery system, but they do not share in healing tissues or repairing defects by themselves [7].

Chitosan (CS) and beta-sodium glycerophosphate (β-GP) based hydrogels are one of the most widely used hydrogels in the biomedical field. These two components have excellent biocompatibility and successfully form a hydrogel at body temperature [8]. Gelatin (a kind of ampholyte) incorporation is also recommended to crosslink CS and β-GP via an electrostatic interaction between anions and cations to reduce the gelation time [9]. All these advantages allow the quick formation of the hydrogel in the irregular tissue defects in-vivo for sustained drug release [10].

Erythropoietin (EPO), a member of the hematopoietic class I cytokine superfamily, is a 34 kDa glycoprotein hormone that maintains normal red blood cells’ count through the regulation of the precursor cells’ proliferation and differentiation and prevention of bone marrow erythroid cells apoptosis [11]. However, EPO receptors have also been detected in cells other than hematopoietic ones such as cells of the nervous system [12], cardiovascular system [13], as well as the basal cells of oral mucosa [14]. EPO showed high potentiality for regeneration of different oral tissues as tongue ulcers [10], and treatment of gingival and periodontal diseases [15–18].

Erythropoietin enhances tissue regeneration following damage via several principal mechanisms. It exerts an anti-inflammatory effect by inhibiting the activity of inflammatory cells and suppressing the release of proinflammatory cytokines such as interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), reactive oxygen species (ROS), and membrane lipid peroxidase [19]. Recently, it has been found that EPO can modulate the immune system bioactivities [20]. Specifically, EPO can enhance the phagocytic capacity of macrophages and facilitate macrophage polarization [21]. EPO has the ability to suppress the proinflammatory M1 macrophage and amplify the anti-inflammatory M2 phenotypes thereby favoring the macrophages immunoregulatory switching by activating a sequence of signaling pathways including mitogen-activated protein kinase (MAPK), phosphoinositide 3 kinase (PI3K), and Janus-tyrosine kinase 2 (Jak2)/signal transducer and activator of transcription (STAT) pathways [22].

EPO also has the capacity to induce more effective tissue restoration by accelerating the formation of granulation tissue during wound healing and its subsequent remodeling [23]. Moreover, it enhances angiogenesis by activating vascular endothelial growth factor (VEGF) which interacts with EPO inducing the formation of new functioning capillaries [24, 25]. In addition, it induces erythrocytes and leukocytes proliferation and differentiation within the defect through acceleration of cellular growth and enhancement of tissue oxygenation [26].

Stem cells are currently gaining a lot of attention as an innovative therapy to enhance the healing of tongue defects. Mesenchymal stem cells (MSCs) are multipotent stromal cells existing in most tissues. They have the capacity to differentiate into multiple cell lineages; adipogenic, chondrogenic and osteogenic. They can escape allogeneic immunogenic reactions and have high potentiality for immunomodulation and for suppressing inflammation [27].

Adipose derived stem cells (ADSCs) are isolated from adipose tissue and can enhance angiogenesis and wound regeneration in soft tissue defects. They have the advantages of being widely available, easily harvested in large number, and relatively easily expanded in culture for clinical use [28]. Even though tremendous advancements have been achieved in the field of stem cell therapy, numerous limitations still need to be addressed. These limitations include poor cell survival, limited cell availability, and even the possibility of tumorigenic transformation [29]. In addition, cells have large molecular size that may result in their entrapment in the pulmonary blood vessels [30].

Stem cell-derived secretome is the reservoir of all the biological factors and molecules that are secreted by the cells and play fundamental roles in many cellular functions such as angiogenesis and immunomodulation in addition to their anti-inflammatory and anti-apoptotic effect [31]. It principally comprises two main constituents, which are soluble factors such as cytokines, growth factors, and enzymes, besides the extracellular vesicle compartment containing proteins, lipids, and nucleic acids [32], and ranging in size from as small as 30 nm to as large as 10 μm [33]. It represents a potential novel cell free therapeutic strategy to manage orofacial soft tissues defects based on the fact that stem cells mediate wound healing mainly via their paracrine mechanisms [34]. Stem cell secretome therapy has revealed promising results in regenerative medicine including hepatic, respiratory and neurological tissue regeneration [35], as well as in wound healing [36, 37], arthritic diseases [38, 39], and immune-mediated diseases [32].

ADSCs release a wide array of growth factors for instance; basic fibroblast growth factor (bFGF), transforming growth factor- beta (TGF-β), keratinocyte growth factor (KGF), hepatocyte growth factor (HGF), and VEGF into their culture media, which mediate the wound-healing effect of ADSCs [40]. Therefore, ADSC-Secretome have comparable capacity to their parent cells to regenerate soft tissue defects with the added advantages of being relatively easy to separate, store and deliver, overcoming the problems of immunogenic rejection and the possibility of tumorigenesis representing an ideal alternate for stem cell based therapy holding a better future for soft tissue therapy [41].

Macrophages play a major role in host immunologic reaction and tissue homeostasis, through identification of various pathogens, their phagocytosis, induction and relief of inflammation, immune regulation, and initiation of tissue-restoration [42]. Their phenotype switches between the pro-inflammatory M1 and the anti-inflammatory M2 according to the signals they receive from their environment [43]. A variety of macrophage-related surface markers can be used to identify their phenotypes which also function in initiating, progressing, and relieving inflammation [44]. M1 subtype expresses CD38, CD86, CD80, formyl peptide receptors (Fpr2), G protein (Gpr18), toll-like receptors (TLR-2, TLR-4) and TNF-α, while M2 subtype expresses CD163, CD206, c-Myc and early growth response gene-2 (Egr2) [45].

To our knowledge no previous studies have compared the regenerative effect of EPO-hydrogel versus that of ADSC-Secretome on tongue defects. So, this study aimed to compare the potentiality of EPO-hydrogel to that of ADSC-Secretome in healing of induced tongue dorsum defects in rat models and explore their effect on anti-inflammatory M2 macrophage.

Materials and methods

Animals

Animal handling was performed in accordance with the guidelines of Mansoura University animal care and use committee with code number: MU-ACUC (DENT.R.24.05.9) and following the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines.

Forty adult, male, healthy, Sprague Dawley rats, aging 10–11 weeks old, and ranging in weight between 250 and 300 g were purchased from the medical experimental research center (MERC) (Mansoura University, Mansoura, Egypt) where all the experimental work was undertaken. Rats were kept in cages measuring 20 cm height and 40 cm length, 3 rats in each cage. The cages were kept in a 26 °C controlled temperature room, with approximately 65–70% humidity, and a light/dark cycle of 12 h.

Rats had free access to commercial diets (fodder containing 23% protein) and water ad libitum. Total and routine medical care and check-ups were applied during the study. All the biosecurity and biosafety procedures were performed following the recommendations of McCormick-Ell J and Connell N [46] where cages were kept in specified rooms, with self-closing doors, impervious and sanitizable surfaces, and handwashing facilities, separated from other animal strains, with only well-trained personnels allowed to access the rooms. Protective laboratory coats, gowns, and protective eyewear were used during surgical procedures to avoid any possible splashes. Double gloves were worn to protect hands during all steps of animal handling.

Animals were anesthetized before defect preparation and administered an analgesic and antibiotic for three days thereafter. Anesthetic overdose was used for animal euthanization, then plastic bags were utilized for wrapping the carcasses before careful transportation to an incinerator for burning.

Erythropoietin loaded CS/β-GP/gelatin hydrogel preparation and characterization

Erythropoietin-loaded hydrogel preparation was performed following a previous protocol by Xu et al. [47]. In brief, chitosan nanoparticles were prepared by dissolving 40 mg of chitosan in 20 mL of acetic acid (0.1%) under agitation. For gelatin crosslinking, 1 mL deionized water was used for liquefaction of 5 mg gelatin at room temperature. 0.22 μm syringe filter was then used for filtering the resulting solutions. After that, 2.8 mL tripolyphosphate (TPP) solution (0.1% W/V) was used for dissolving 1.02 g of β-GP followed by filtering using a 0.22 μm syringe filter.

For EPO loading, 2.21 mL of EPO (ATC code: B03XA01, Janssen-Cilag Ltd, High Wycombe, Bucks, UK, 10000 U/mL) was added to the prepared solutions and when a uniform mixture was obtained, a solution of sodium hydroxide (NaOH) (0.1 mol/L) was added dropwise until a 7.0 pH was reached. Finally, the assembled EPO loaded CS/β-GP/Gelatin hydrogel was incubated at 37 °C for 5 min.

For characterization of the prepared EPO-hydrogel, particle size and distribution, as well as Zeta potential were analyzed using dynamic light scattering (DLS) (Zetasizer Nano ZN, Malvern Panalytical Ltd, United Kingdom) at fixed angle of 173° at 25 °C, where analysis was performed in triplicates. The average measurement of the particle size was 349.5 ± 12.45 nm, whereas Zeta potential recorded an average of 11.2 ± 0.90 mV.

ADSCs isolation

ADSCs were isolated from six, healthy, Sprague Dawley rats weighing 200–250 g (8–9 weeks of age) per our previous protocol [48]. Briefly, the adipose tissue of rats’ supra-renal fats was collected and washed thoroughly. The collected tissues were minced into small pieces, followed by digestion in 0.1% type I collagenase (cat. #SCR103, EMD Millipore Corp, Billerica, USA), at 37 ⁰C for one hour. To stop the digestive action of the added enzyme, Dulbecco’s modified eagle medium (DMEM) culture media (cat. #L0066-500, BioWest, Nuaillé, France) complemented with 10% fetal bovine serum (FBS) (cat. #S1810-500, BioWest, Nuaillé, France) was added. Cells were then incubated at 5% CO2 and 37 ⁰C and the media was changed every 2–3 days thereafter. Cells were examined on daily basis using an inverted microscope (Olympus, CKX41SF, Tokyo, Japan) until 80% confluence was confirmed.

ADSCs characterization

The flowcytometric immunophenotype characterization of ADSCs was carried out using direct staining technique in a BD Accuri C6 flow cytometer (BD Biosciences, California, USA) and BD Cell Quest TM Pro version 6.0 program software. Third passage cells were trypsinized, washed with phosphate buffered saline (PBS) and incubated with the primary antibodies; anti-CD90 PE (BD Biosciences, cat. #551401, California, USA), anti-CD73 purified (BD Biosciences, cat. #551123, California, USA), anti-CD34 purified (R&D systems, cat. #AF6518-SP, Minneapolis, USA), and anti-CD45 FITC MAB (BD Biosciences, cat. #561867, California, USA). Fluorescein isothiocyanate (FITC, cat. #F143, Thermo Fisher Scientific, Massachusetts, USA) was added to the purified antibodies as a fluorophore, then incubated in the dark at 4 °C for 30 min. Labeled ADSCs were rinsed in PBS, then centrifuged for 5 min at 200×g, followed by their resuspension in PBS.

ADSC-Secretome preparation

ADSC-Secretome was prepared following our previous protocol [38] where third passage ADSCs (4 × 106) were collected after reaching 80–90% confluence, washed three times with PBS and then cultured in FBS-free media for 48 h. After that, the media was collected, centrifuged, and then the supernatant was filtered through a 0.2 μm filter and stored at -80 °C.

Surgical preparation of mechanical tongue defects

For the adjustment of different drugs’ administration doses, each rat (10–11 weeks old) was weighed before any surgical intervention. Animals were anesthetized using 5–7 mg/kg xylazine hydrochloride (ADWIA, 5th Settlement New Cairo, Egypt) and 35–45 mg/kg ketamine hydrochloride (Pfizer, NY, USA) intramuscular injection. Betadine was used for wiping rats’ tongues before defect preparation. Following our previous protocol [41], the defects were prepared in the median line of the dorsal surfaces of the tongues, in the middle thirds. A tissue punch centered 5.0 mm rotary (cat. #N-1042B, OrthoSourceglobal, North Hollywood, CA 91605, USA) was used for preparation of defects measuring 5 mm in diameter and 2 mm in depth (Fig. 1). Surgical scissors were then used to incise the tissues. Instantly following defect preparation, the tested therapies were administered through injection at the peripheries of the wound. As a postoperative antibiotic and analgesic treatment, rats received a daily dose of oxytetracycline hydrochloride 20% and analgin 0.5 mg via intraperitoneal injection for three days thereafter.

Fig. 1 A. Tongue dorsum surgical defect preparation, B. Circular tongue defect

Study design

This was an experimental, randomized controlled study. Calculation of the sample size was performed based on a previous study depending on the average ulcer depth in the control and EPO groups after 14 days [10]. Calculations were performed through G*power version 3.1.9.4 with effect size of 2.5458, 2-tailed test, α error 0.05, and power 95.0%. The size was found to be at least 6 in each group.

Four rats were euthanized at the start of the experiment to evaluate the normal histology of rat’s tongue. The remaining rats were subjected to induction of mechanical tongue defect and then allocated to three different groups (n = 12) following a simple random sampling method according to the type of treatment that was injected circumferentially around the wound margins immediately after defect preparation as follows:

Group I (control)

Tongue defects received 0.1 ml PBS.

Group II (EPO hydrogel)

Tongue defects received a single dose of EPO hydrogel (5000 U/kg) [10, 49].

Group III (ADSC-Secretome)

Tongue defects received 0.1 ml ADSC-Secretome [41].

Intraperitoneal injection of anesthetic overdose (120 mg/kg thiopental sodium, alfa chemical group, Cairo, Egypt) was used for euthanasia [50]. Out of each group, six rats were euthanized at 7 and 14 days after defect induction. Tongue samples were obtained and processed for histological and immunohistochemical investigations.

Histological and immunohistochemical staining

After collection and fixation of tongue specimens in neutral-buffered formalin, they were processed to prepare paraffin blocks. Using a microtome, 4 μm tissue sections were serially cut, followed by their deparaffinization, rehydration, and staining. Hematoxylin and eosin staining (H&E) was performed for monitoring the histological changes and evaluating the regenerative process through the healing period.

Immunohistochemical staining was performed for detection of anti-inflammatory M2 macrophage phenotype through CD163 marker (Recombinant Anti-CD163 antibody, cat. # ab182422, Abcam, Cambridge, UK, dilution 1:500). Briefly, blocking of endogenous peroxidase was carried out using H2O2, followed by antigen retrieval through boiling in citrate buffer, then incubation with CD163 primary antibody. After that, slides were incubated with the secondary biotinylated antibody, followed by streptavidin biotin complex. Diaminobenzidine chromogen (DAB substrate kit, cat. # ab64238, Abcam, Cambridge, UK) was then added followed by counterstaining with Harris hematoxylin.

Digital histomorphometrical image analysis

H&E-stained tissue sections were examined and photographed using a digital camera (ToupCam®, model no. XCAM1080PHA) mounted on light microscope (Olympus®, CX22, Japan), with 0.5 photo adaptor, using 10x objective lens. For immunohistochemically stained sections, five different sites (1 × 1 mm2) in each slide were assessed through a 20x objective lens by two blinded examiners.

For digital image analysis, image processing software Fiji ImageJ (version 2; NIH, Maryland, USA) was utilized. For vertical defect depth measurements, the ulcer depth was calculated for each slide using the measuring function after image calibration where three readings were recorded from each slide from the deepest points in the defects to the top of surface epithelium at wound margins. For immunohistochemical stained sections, the percentage of positive brown staining area to the total area was calculated regardless of stain intensity where the function color deconvolution 2 tool was used to digitally separate the histological dyes in the microphotographs resulting in three digital images (a complementary image, H&E, and DAB), after which the stain-specific area percentage in DAB and H&E images was calculated. Data was presented as the mean of the vertical depth or positive brown staining percentage ± standard deviation.

Statistical analysis

Data was analyzed using GraphPad Prism 9 (GraphPad Software). The normality of data was tested using the Shapiro-Wilk test. Normally distributed quantitative data was presented as mean ± standard deviation. Significance of the acquired results was judged at the 0.05 level. The two-way ANOVA test was used to assess the combined effect of time and intervention independent factors on the dependent continuous outcomes which were defect depth, and CD163 antibody immunostaining using Post Hoc Tukey test for pairwise comparison.

Results

ADSCs characterization results

ADSCs adhered to plastic walls with typical fibroblast-like and spindle shaped morphology (Fig. 2A). The third passage ADSCs revealed highly positive results for the phenotypic cell surface mesenchymal markers CD90 (93.7%) and CD73 (94.4%) and negative results for the hematopoietic markers CD34 (1.7%) and CD45 (2.9%). (Fig. 2B-E)

Fig. 2 A. ADSC confluence. Flowcytometry histograms for ADSC phenotypic characterization.  B. CD90,  C. CD73,  D. CD34,  E. CD45

H&E results

The normal tongue specimens showed regular tongue histology with full thickness epithelium covered by a uniform even keratin layer. Filiform papillae covered the dorsum of the tongue with some intervening fungiform papillae carrying taste buds. The lamina propria showed regular collagen bundles with proper interdigitation with the epithelial rete pegs, and a highly arranged muscular system was observed with different muscle bundles’ orientation. (Figures 3A and 4A)

Seven days after mechanical defect induction and different interventions, the control group specimens showed wide and deep defects with complete loss of epithelium and connective tissue at the defect site. Granulation tissue with much inflammatory cell infiltrate was observed. The lateral wound margins presented some irregular re-epithelization and no signs of muscular regeneration in the deep underlying tissues was detected. (Figures 3B, 4B and 5A)

Fig. 3 Hematoxylin and Eosin staining results of tongue specimens of different groups (4x) A. normal tongue, B, E. control group, C, F. EPO-hydrogel group, and D, G. ADSC-Secretome group. E: epithelium, CT: connective tissue, M: muscles, D: defect, FL: filiform papilla, FN: fungiform papilla, Asterisk: inflammatory infiltrate

Fig. 4 Hematoxylin and Eosin staining results of tongue specimens of different groups (10x) A. normal tongue, B, E. control group, C, F. EPO-hydrogel group, and D, G. ADSC-Secretome group. E: epithelium, CT: connective tissue, M: muscles, D: defect, FL: filiform papilla, FN: fungiform papilla, Asterisk: inflammatory infiltrate, Arrowhead: taste bud

Fig. 5 Hematoxylin and Eosin staining results of tongue specimens of different groups (40x) A, D. control group, B, E. EPO-hydrogel group, and C, F. ADSC-Secretome group. Asterisk: inflammatory infiltrate, Arrowhead: blood vessel, MS: muscles

In the EPO treated group, the wounds seemed smaller in size, and the lateral margins showed some epithelial regeneration with some keratin covering. Moreover, the base of the defects started to show some epithelial re-organization, and some muscle fibers. However, much granulation tissue was still found with many inflammatory cells, and little neovascularization was detected. (Figures 3C, 4C and 5B)

In the ADSC-Secretome treated group, some regeneration was also detected. Granulation tissue with inflammatory cells were observed in the wound site. More new blood vessels were formed, and the lateral margins also presented developing epithelial tongues with keratin coverage. Some muscle fibers were detected in the deep connective tissue. (Figures 3D, 4D and 5C)

Fourteen days after induction, defects of the control group still showed some deepening from the surface level. However, complete epithelial coverage was observed, but with thin, irregular keratin layer and no tongue papillae. The connective tissue expressed good healing with some blood vessels and some muscle regeneration at the depth of the defect. (Figures 3E, 4E and 5D)

The EPO-treated group showed much better regeneration as compared to the control group and to the same group at seven days. Mucosal ulceration disappeared in most tongue specimens and the surface was completely covered with epithelium showing a thin keratin layer. Regular rete pegs were observed interdigitating with the underlying connective tissue papillae. The lamina propria showed collagen bundles with new blood vessel formation. More muscle bundle re-organization was detected at the depth of the defect. However, tongue papillae were not restored through the whole defect area. (Figures 3F, 4F and 5E)

Specimens of the ADSC-Secretome treated group expressed much better healing with more regular epithelial and keratin layers with uniform thickness. Developing filiform papillae were observed. The connective tissue showed more arranged collagen bundles and more vascularity. Well-arranged muscle bundles were detected as well. (Figures 3G, 4G and 5F)

Histomorphometric results

Table 1 Post Hoc Tukey test for pairwise comparison of factors affecting defect depth (µm)

Intervention
Time	Control	EPO	ADSC-Secretome	
7 days	482.42 ± 81.03	206.82 ± 43.21 a	139.36 ± 21.01 a	
14 days	321.19 ± 22.64 *	53.39 ± 10.10 a*	41.15 ± 4.67 a*	
Data presented as Mean ± SD, Significance at p < 0.05

a:Significance Vs control group within the same time point

*: Significance Vs 7 days within the same group

Defect depth analysis confirmed the therapeutic influence of both treatments on tongue ulcers, where the defect measurements were very much reduced (Table 1) (Fig. 6A). The two-way ANOVA analysis showed insignificant interaction between the intervention and the time factors on the tongue defect depth [F [2, 24] = 1.862, p = 0.1771], therefore main effect analysis of each factor was reported.

As regards the intervention factor, a significant main effect was detected [F [2, 24] = 181.4, p < 0.0001], where the EPO and ADSC-Secretome groups showed significantly reduced defect depth as compared to the control group at both time intervals (p < 0.0001). However, both treatment groups didn’t differ significantly at 7 days (p = 0.1168), or at 14 days (p = 0.9962).

As for time factor, a significant main effect was also expressed [F [1, 24] = 89.62, p < 0.0001]. The pairwise comparison showed significantly lower values for all groups at 14 days’ time point versus 7 days with p values of < 0.0001, < 0.0001, and 0.0079 for the control, EPO, and ADSC-Secretome groups, respectively.

Fig. 6 Bar graphs showing the two-way ANOVA statistical analysis for: A. defect depth, B. anti-CD163 immunohistochemical staining results. Asterisk: denotes statistical significance

Immunohistochemical results

Fig. 7 Immunostaining for CD163 antibody for different groups at 7 and 14 days (20x) A, D. control group, B, E. EPO-hydrogel group, and C, F. ADSC-Secretome group. Arrowhead: denotes positive brown staining areas

Table 2 Post Hoc Tukey test for pairwise comparison of factors affecting CD163 IHC positive staining surface area percentage

Intervention
Time	Control	EPO	ADSC- Secretome	
7 days	3.53 ± 0.86	25.77 ± 5.61 a	27.65 ± 6.03 a	
14 days	12.59 ± 4.25	34.38 ± 7.11 a	57.77 ± 11.41 ab*	
Data presented as Mean ± SD Significance at p < 0.05

a:Significance Vs control group within the same time point

b: Significance Vs EPO group within the same time point

*: Significance Vs 7 days within the same group

The positive CD163 immunohistochemical reaction was detected as brown deposits in the cytoplasm and cellular membrane (Fig. 7). CD163 expression, as a marker for M2 macrophage, denoting the anti-inflammatory activity, showed the highest levels in ADSC-Secretome group, followed by EPO, and control groups, respectively. Moreover, there was a time dependent increase at 14 days than 7 days. (Table 2) (Fig. 6B).

Two-way ANOVA analysis revealed a significant interaction between intervention and time factors on the expression of CD163 M2 macrophage marker [F [2, 24] = 8.479, p = 0.0016]. Therefore, a simple main effect analysis of the factors was performed. Regarding the simple main effect of the intervention factor, the pairwise comparison showed that both treatment groups; EPO and ADSC-Secretome expressed significantly higher mean values as compared to the control group at 7 days (p = 0.0003 and p < 0.0001) as well as 14 days (p = 0.0004 and p < 0.0001), respectively. However, no significant difference was detected between EPO and ADSC-Secretome groups at 7 days (p = 0.9975), but after 14 days, ADSC-Secretome group showed significantly higher CD163 expression (p = 0.0001).

Regarding the simple main effect of the time factor, no significant difference was detected between groups at the two time points, except for ADSC-Secretome group which showed significantly higher mean values at 14 days as compared to 7 days. However, control and EPO groups expressed higher mean values at 14 days than at 7 days (p = 0.2981, p = 0.351, and p < 0.0001 for control, EPO, and ADSC-Secretome groups, respectively).

Discussion

Regenerative tissue engineering has been successfully implicated in the regeneration of different oral tissues, but the tongue as a vital organ hasn’t been adequately addressed in research [51]. Tongue is affected by various pathological abnormalities, including malignancies which usually require surgical resection, not only to limit the tumor growth and metastasis, but also to save the patients’ lives [52]. Unfortunately, even minor excisions affect tongue functions such as swallowing and speech, thereby adversely affecting the quality of life. Typically, these resections are reconstructed using autologous skin flaps. However, this line of treatment has many limitations regarding restoration of physiological functions [53]. The alternate strategy, despite not fully developed, is reconstructing new tissues through regenerative medicine [51]. So, the present study aimed to evaluate the regenerative potential of erythropoietin hydrogel and ADSC-Secretome in healing of mechanically induced tongue defect models and tracking the anti-inflammatory M2 macrophage through the healing process.

Animal models are widely used in experimental studies for the assessment of various disorders. It has been found that the physiological body functions of rats, as mammalians, are nearly similar to those of human beings. In addition, rats have an immune system that can withstand the induction of a variety of diseases [54]. A circular defect size of 5 mm diameter and 2 mm depth was considered a critical sized defect based on previous studies [10, 41, 55] and relying on the lack of complete spontaneous healing by the 14th day as confirmed histologically and histomorphometrically in the present study.

EPO loaded CS/β-GP/gelatin hydrogel was successfully formulated and characterized. The average particle size measured 349.5 ± 12.45 nm which is consistent with our previous study where the same EPO preparation was found to be 345.5 ± 13.01 nm [10]. This is also similar to a study by Nguyen et al. [56], who reported that the average size of EPO/magnetic nanoparticles drug delivery system was no more than 500 nm. Similarly, the average particle size for recombinant human EPO encapsulated in CS nanoparticles/TPP gel was found to range between 100 and 400 nm [57]. This moderate nanoparticle size may contribute to good regenerative potentials where according to Yue et al. [58], small nano-sized particles are faster and more uptaken by cells than micro-sized ones.

Zeta potential for the current EPO hydrogel delivery system was found to be 11.2 ± 0.90 mV. Concomitantly, in our previous study the particles expressed a zeta potential of 12.1 ± 0.87 mV [10]. Our results are also in accordance with other studies where the zeta potential of EPO-loaded trimethyl CS/TPP nanoparticles, and CS-Coated Azithromycin/Ciprofloxacin-loaded polycaprolactone nanoparticles were reported to be 11.5 ± 1.8 mV and 8–11 mV, respectively [59, 60]. According to Kumar and Dixit [61], solutions with particle zeta potential that ranges between 10 and 30 mV are considered of incipient stability. Moreover, CS was reported to decrease the particle surface charge [57].

In the current study, the control group showed deep, incompletely healed wounds, which is consistent with Xu et al. [62] who detected minor wound re-epithelization after four days of mechanical tongue ulcer induction, while after fourteen days some epithelial regeneration was observed, but without muscle re-organization. Concomitantly, in the present study, intense inflammatory infiltration was observed initially. However, after fourteen days, gradual regeneration and neovascularization with irregular epithelial coverage was detected with minimal muscle regeneration and no tongue papillae restoration. In our previous study [41], mechanical tongue wounds were examined at four, seven, and fourteen days postoperatively and similar findings were detected. These results agree with the fact that oral wound healing follows consecutive phases of inflammation, proliferation and maturation [63].

In the present study, EPO treated group showed significant decrease in defect depth and acceleration of wound healing compared to the control group. These results are in corroboration with our previous study [10], where treatment of tongue defects with EPO loaded CS/β-GP/gelatin hydrogel significantly accelerated tissue regeneration and filling of tongue defects, improved neovascularization, and reduced tissue inflammation as evidenced by the significant increase in VEGF and decrease in inducible nitric oxide synthase (iNOS) tissue levels, respectively. Similar studies conducted by Gu et al. [64] and Farid et al. [18] reported that injectable chitosan/β-GP/glycolic acid thermosensitive hydrogel loaded with EPO successfully alleviated gingival inflammation and enhanced the regeneration of periodontal tissue where EPO modulated the inflammatory mediators specially IL-1 β, IL-6 and TNF-α.

Similarly, in a study conducted by Javadmoosavi et al. [26] on the effect of EPO on the tissue-healing process, EPO-treated groups showed significant decrease in inflammatory cell density, increase in fibroblast number, neovascularization, and enhanced epithelial thickness at the wound margins compared to the control group. Consistently, mucoadhesive gel based on trimethyl chitosan containing EPO expressed better healing and epithelization of chemotherapy-induced oral mucositis in rat models [65]. Moreover, in several clinical studies conducted by Yaghobee et al. [16, 17], EPO topical application effectively enhanced palatal and gingival wound healing and reduced inflammation after free gingival graft procedures.

These positive regenerative impacts could be attributed to the ability of EPO to antagonize the proinflammatory pathways, inhibit apoptosis, and enhance neovascularization [66]. Moreover, using CS/β-GP based hydrogel, as a drug delivery system, promoted the healing process owing to its ease of application and injection into tissue spaces, gelation at body temperature, besides the sustained release of the loaded active ingredients which was optimized through gelatin incorporation that rapidly crosslinked CS with β-GP reducing gelation time [67].

In the present study, the histological sections of the ADSC-Secretome treated group showed almost no mucosal ulceration and better regenerated tissues with more regular epithelial layer with developing lingual papillae and re-organized muscle bundles. Also, there was an enhancement in neovascularization compared to EPO group which could be attributed to the fact stated by Bronckaers et al. [68] where ADSC-Secretome comprises a vast array of signaling molecules promoting angiogenesis.

These results are in accordance with our previous study [41], where ADSC-Secretome achieved promising results on the mucosal tongue defect healing; regenerating a well-organized epithelium with regular keratin layer, and the underlying connective tissue exhibited signs of muscle regeneration with more arranged collagen bundles which was attributed to the anti-inflammatory effect of ADSC-Secretome marked by downregulation of IL-6 and enhanced cellular proliferation confirmed by elevated levels of proliferating cell nuclear antibody (PCNA).

Concomitantly, in a study by Jaheen et al. [69], bone marrow stem cell-derived secretome (BMSC-Secretome) was found to enhance the healing of buccal oral ulcers showing histological re-epithelization, neovascularization, increased collagen content, and VEGF expression. ADSC-Secretome was also reported to promote the healing of full thickness skin wounds in rats showing normal epidermal regeneration after eleven days [70].

ADSC-Secretome was found to exert an anti-inflammatory effect through downregulation of activator protein-1 (AP-1), nuclear factor kappa B (NF-κB) and MAPKs signaling pathways and reduced IL-6 levels [71]. In the same context, ADSC-Secretome was found to possess anti-apoptotic influence on different cell types such as cardiomyocytes, endothelial cells, muscle cells, and epithelial cells [72], and according to Coulange Zavarro et al. [73] this antiapoptotic potential is mediated through several factors comprising TGF-β1, VEGF, HGF, Insulin-like Growth Factor-1 (IGF-1), and FGF. These factors can also recruit endothelial cells to ischemic sites enhancing neovascularization [68].

The enhanced re-epithelization could also be attributed to the facts stated by Chicharro el al. [74] where ADSCs release several growth factors that enhance re-epithelization which induce the required biological responses for tissue regeneration comprising cellular proliferation, migration, and differentiation in addition to extracellular matrix production, promotion of angiogenesis and resolution of inflammation.

However, even in ADSC-Secretome group the newly regenerated epithelium didn’t show fully developed lingual papillae and taste buds which could be attributed to their sophisticated histology which could require longer time to be fully developed which was consistent with the study conducted by Zhang et al. [75] where even after 56 days the lingual papillae and taste buds didn’t achieve full development.

Moreover, in the treated groups the underlying connective tissue only showed signs of muscle regeneration at the fourteenth day without complete restoration to normal structure, whereas epithelium and connective showed earlier full regeneration. These findings coincide with Xu et al. [62] where gingival-derived MSC (GMSCs) treated group achieved only a small percentage for positive expression of several key myogenic transcriptional factors Myf5, MyoD, and PAX7. In our previous studies, the regeneration of tongue musculature was also postponed to later stages [10, 41] which indicates that muscle repair might require longer time than mucosal epithelium or connective tissue regeneration.

In response to environmental influences, macrophages undergo modulation between the pro-inflammatory M1 and the anti-inflammatory M2 phenotypes [43]. CD163 is an M2-macrophage specific antigen involved in tissue remodeling and release of immune-modulatory mediators such as IL-4, IL-10, IL-13, and TGF-β [76]. It is considered to be highly specific for M2 macrophage phenotype according to literature [77–79].

In the current study, EPO and ADSC-Secretome treatments significantly enhanced the anti-inflammatory effect through promoting the upregulation of M2 macrophage phenotype as evidenced by upregulation of CD163 marker. Concomitantly, in a study by Li et al. [80], EPO hydrogel, through suppression of ROS levels, successfully shifted macrophage polarization from M1 to M2 enhancing tissue regeneration in periodontitis where M1 macrophage markers (IL-1β, IL-6, and TNF-α) were down-regulated while M2 macrophage markers (IL-10, Arg-1, and TGF-β) were upregulated. This modulation decreases the levels of matrix metalloproteinase-9 (MMP-9) and cyclooxygenase-2 (COX-2) favoring healing through restoration of homeostasis [18].

Kruger et al. [81] declared that ADSC-Secretome can restore the inflammatory balance through promotion of M2 macrophage phenotype and increasing the percentage of cells expressing CD206, CD163, and IL10. In the same context, Li et al. [82] found that ADSC-exosomes can control M1/M2 macrophage phenotypic shift promoting healing through regulation of miR-451a macrophage migration inhibitory factor.

In contrast to our results, a study on the impact of intraperitoneal EPO injection on ischemic wound healing in rat models found that it enhanced tissue healing in the early stages, but later it hindered regeneration which was attributed to high hemoglobin and hematocrit values, that may have affected the efficiency of microcirculation [83]. Regarding the therapeutic influence of MSC-Secretome, Conforti et al. [84] informed that, compared to native whole cells, MSC-Secretome didn’t achieve the required immunomodulation which they attributed to lack of cell to cell contact required to regulate inflammatory cells proliferation and function. Moreover, in a model of acute renal injury studied by Gabr et al. [85], intravenous administration of BMSC-Secretome didn’t show significant regenerative effects. Controversies between the results of different studies of different treatments are largely accredited to different tissues, injury models, doses and formulations of different therapeutic agents, delivery systems, preparation protocols, evaluation periods, and the implicated assessment parameters.

From the limitations of the current study is the lack of comparison of different EPO and ADSC-Secretome concentrations that may have influenced their therapeutic potentials. Moreover, in the present study, only histological and immunomodulatory analysis were performed which doesn’t fully explain the different biological processes yielding tissue regeneration. Only one marker for M2 macrophage was used in the present study which could have been supported by other markers, however CD163 is considered to be highly specific for M2 macrophage. In addition, the composition of ADSC-Secretome, which comprises a large pool of diverse biological molecules, wasn’t investigated.

So further future studies are required to address these limitations. More analysis for the different phases of the tissue healing process is needed to elucidate the typical underlying tissue repair mechanisms. Moreover, detailed compositional analysis of the secretome accompanied by long term follow up assessment is mandatory to ensure its safety before translation to human clinical studies.

Conclusion

Eventhough ADSC-Secretome showed better results, both EPO-hydrogel and ADSC-Secretome showed promising and comparable results in the treatment of tongue wounds with significant reduction in defect depth and significant upregulation of the anti-inflammatory M2 macrophage phenotype suppressing inflammation thus enhancing healing and regeneration of tongue tissues. Therefore, the use of ADSC-Secretome is recommended as a cell free therapy overcoming the concerns associated with the use of stem cells and at the same time, EPO-hydrogel is presented as a potential, affordable, and easily obtained therapy.

Acknowledgements

Not applicable.

Author contributions

RE: Investigation, Collection and assembly of data; JY: Conception, design and supervision; EH: Methodology, material preparation, data analysis and interpretation; All authors contributed to data interpretation, writing and revision and approved the final manuscript.

Funding

None.

Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).

Data availability

All the produced data is included in this article.

Declarations

Ethical approval

Animal handling was performed in accordance with the guidelines of Mansoura University animal care and use committee with code number: MU-ACUC (DENT.R.24.05.9) and following the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Abbreviations

EPO Erythropoietin

ADSCs Adipose derived stem cells

β-GP β-sodium glycerophosphate

IL-1β Interleukin-1β

IL-6IL-6 Interleukin-6

TNF-α Tumor necrosis factor-alpha

MAPKs Mitogen-activated protein kinases

PI3K Phosphoinositide 3 kinase

TPP Tripolyphosphate

VEGF Vascular endothelial growth factor

MSCs Basic fibroblast growth factor

TGF-β Transforming growth factor- beta

KGF Keratinocyte growth factor

HGF Hepatocyte growth factor

Fpr2 Formyl peptide receptors

Gpr18 G protein

TLR Toll-like receptors

Egr2 Early growth response gene-2

MU-ACUC Mansoura University animal care and use committee

MERC Medical experimental research center

TPP Tripolyphosphate

NaOH Sodium hydroxide

DLS Dynamic Light Scattering

DMEM Dulbecco’s modified eagle medium

FBS Fetal bovine serum

PBS Phosphate buffered saline

FITC Fluorescein isothiocyanate

H&E Hematoxylin and eosin

ANOVA Analysis of variance

iNOS Inducible nitric oxide synthase

PCNA Proliferating cell nuclear antibody

IGF-1 Insulin-like Growth Factor-1

AP-1 activator protein-1

NF-κB Nuclear factor kappa B

ROS Reactive oxygen species

MMP-9 Matrix metalloproteinase-9

COX-2 Cyclooxygenase-2

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Sanders I Mu L A three-dimensional atlas of human tongue muscles Anat Rec (Hoboken) 2013 296 7 1102 14 10.1002/ar.22711 23650264
Sanders I, Mu L. A three-dimensional atlas of human tongue muscles. Anat Rec (Hoboken). 2013;296(7):1102–14. 10.1002/ar.22711.23650264
2. Beck-Broichsitter BE Huck J Küchler T Hauke D Hedderich J Wiltfang J Self-perception versus professional assessment of functional outcome after ablative surgery in patients with oral cancer J Cancer Res Clin Oncol 2017 143 2 305 11 10.1007/s00432-016-2287-0 27757527
Beck-Broichsitter BE, Huck J, Küchler T, Hauke D, Hedderich J, Wiltfang J, et al. Self-perception versus professional assessment of functional outcome after ablative surgery in patients with oral cancer. J Cancer Res Clin Oncol. 2017;143(2):305–11. 10.1007/s00432-016-2287-0.27757527
3. Mangold AR, Torgerson RR, Rogers RS 3. Diseases of the tongue. Clin Dermatol. 2016;34(4):458–69. 10.1016/j.clindermatol.2016.02.018.
4. Aldelaimi T Khalil A Lingual Solitary squamous cell papilloma Al- Anbar Med J 2022 18 1 51 51 10.33091/amj.2021.174532
Aldelaimi T, Khalil A. Lingual Solitary squamous cell papilloma. Al- Anbar Med J. 2022;18(1):51–51. 10.33091/amj.2021.174532.
5. Salar Amoli M EzEldeen M Jacobs R Bloemen V Materials for Dentoalveolar Bioprinting: current state of the art Biomedicines 2021 10 1 71 10.3390/biomedicines10010071 35052751
Salar Amoli M, EzEldeen M, Jacobs R, Bloemen V. Materials for Dentoalveolar Bioprinting: current state of the art. Biomedicines. 2021;10(1):71. 10.3390/biomedicines10010071.35052751
6. Chai Q Jiao Y Yu X Hydrogels for Biomedical Applications: their characteristics and the mechanisms behind them Gels 2017 3 1 6 10.3390/gels3010006 30920503
Chai Q, Jiao Y, Yu X. Hydrogels for Biomedical Applications: their characteristics and the mechanisms behind them. Gels. 2017;3(1):6. 10.3390/gels3010006.30920503
7. Li S Dong S Xu W Tu S Yan L Zhao C Antibact Hydrogels Adv Sci (Weinh) 2018 5 5 1700527 10.1002/advs.201700527
Li S, Dong S, Xu W, Tu S, Yan L, Zhao C, et al. Antibact Hydrogels Adv Sci (Weinh). 2018;5(5):1700527. 10.1002/advs.201700527.
8. Supper S Anton N Seidel N Riemenschnitter M Curdy C Vandamme T Thermosensitive chitosan/glycerophosphate-based hydrogel and its derivatives in pharmaceutical and biomedical applications Expert Opin Drug Deliv 2014 11 2 249 67 10.1517/17425247.2014.867326 24304097
Supper S, Anton N, Seidel N, Riemenschnitter M, Curdy C, Vandamme T. Thermosensitive chitosan/glycerophosphate-based hydrogel and its derivatives in pharmaceutical and biomedical applications. Expert Opin Drug Deliv. 2014;11(2):249–67. 10.1517/17425247.2014.867326.24304097
9. Bazoobandi S Tanideh N Rahmanifar F Zare S Koohi-Hosseinabadi O Razeghian-Jahromi I Preventive effects of Intrauterine Injection of Bone Marrow-derived mesenchymal stromal cell-conditioned media on Uterine Fibrosis immediately after endometrial curettage in rabbit Stem Cells Int 2020 2020 1 8849537 10.1155/2020/8849537 33204278
Bazoobandi S, Tanideh N, Rahmanifar F, Zare S, Koohi-Hosseinabadi O, Razeghian-Jahromi I, et al. Preventive effects of Intrauterine Injection of Bone Marrow-derived mesenchymal stromal cell-conditioned media on Uterine Fibrosis immediately after endometrial curettage in rabbit. Stem Cells Int. 2020;2020(1):8849537. 10.1155/2020/8849537.33204278
10. Ata F El-Qashty R Farid M Youssef J Healing of induced tongue defects using erythropoietin hydrogel (an experimental study on rats) BMC Oral Health 2024 24 1 391 10.1186/s12903-024-04161-5 38539151
Ata F, El-Qashty R, Farid M, Youssef J. Healing of induced tongue defects using erythropoietin hydrogel (an experimental study on rats). BMC Oral Health. 2024;24(1):391. 10.1186/s12903-024-04161-5.38539151
11. Bhoopalan SV, Huang LJ, Weiss MJ. Erythropoietin regulation of red blood cell production: from bench to bedside and back. F1000Res. 2020;9. 10.12688/f1000research.26648.1.
12. Vittori DC Chamorro ME Hernandez YV Maltaneri RE Nesse AB Erythropoietin and derivatives: potential beneficial effects on the brain J Neurochem 2021 158 5 1032 57 10.1111/jnc.15475 34278579
Vittori DC, Chamorro ME, Hernandez YV, Maltaneri RE, Nesse AB. Erythropoietin and derivatives: potential beneficial effects on the brain. J Neurochem. 2021;158(5):1032–57. 10.1111/jnc.15475.34278579
13. Auzmendi J Puchulu MB Rodriguez JCG Balaszczuk AM Lazarowski A Merelli A EPO and EPO-Receptor system as potential actionable mechanism for the Protection of Brain and Heart in Refractory Epilepsy and SUDEP Curr Pharm Des 2020 26 12 1356 64 10.2174/1381612826666200219095548 32072891
Auzmendi J, Puchulu MB, Rodriguez JCG, Balaszczuk AM, Lazarowski A, Merelli A. EPO and EPO-Receptor system as potential actionable mechanism for the Protection of Brain and Heart in Refractory Epilepsy and SUDEP. Curr Pharm Des. 2020;26(12):1356–64. 10.2174/1381612826666200219095548.32072891
14. Peng B Kong G Yang C Ming Y Erythropoietin and its derivatives: from tissue protection to immune regulation Cell Death Dis 2020 11 2 79 10.1038/s41419-020-2276-8 32015330
Peng B, Kong G, Yang C, Ming Y. Erythropoietin and its derivatives: from tissue protection to immune regulation. Cell Death Dis. 2020;11(2):79. 10.1038/s41419-020-2276-8.32015330
15. Zakaria MF Sonoda S Kato H Ma L Uehara N Kyumoto-Nakamura Y Erythropoietin receptor signal is crucial for periodontal ligament stem cell-based tissue reconstruction in periodontal disease Sci Rep 2024 14 1 6719 10.1038/s41598-024-57361-y 38509204
Zakaria MF, Sonoda S, Kato H, Ma L, Uehara N, Kyumoto-Nakamura Y, et al. Erythropoietin receptor signal is crucial for periodontal ligament stem cell-based tissue reconstruction in periodontal disease. Sci Rep. 2024;14(1):6719. 10.1038/s41598-024-57361-y.38509204
16. Yaghobee S Rouzmeh N Aslroosta H Mahmoodi S Khorsand A Kharrazifard MJ Effect of topical erythropoietin (EPO) on palatal wound healing subsequent to free Gingival Grafting (FGG) Braz Oral Res 2018 32 e55 10.1590/1807-3107bor-2018.vol32.0055 29898030
Yaghobee S, Rouzmeh N, Aslroosta H, Mahmoodi S, Khorsand A, Kharrazifard MJ. Effect of topical erythropoietin (EPO) on palatal wound healing subsequent to free Gingival Grafting (FGG). Braz Oral Res. 2018;32:e55. 10.1590/1807-3107bor-2018.vol32.0055.29898030
17. Yaghobee S Rouzmeh N Taheri M Aslroosta H Mahmoodi S Mohammadnejad Hardoroodi M Evaluation of topical erythropoietin application on the healing outcome of gingival graft recipient site; a randomized controlled clinical trial BMC Oral Health 2021 21 1 578 10.1186/s12903-021-01948-8 34772399
Yaghobee S, Rouzmeh N, Taheri M, Aslroosta H, Mahmoodi S, Mohammadnejad Hardoroodi M, et al. Evaluation of topical erythropoietin application on the healing outcome of gingival graft recipient site; a randomized controlled clinical trial. BMC Oral Health. 2021;21(1):578. 10.1186/s12903-021-01948-8.34772399
18. Farid M Ata F Elhennawy ES Youssef J Can Erythropoietin open a Novel Avenue for Periodontal Regeneration? Cureus 2024 16 1 e52825 10.7759/cureus.52825 38406126
Farid M, Ata F, Elhennawy ES, Youssef J. Can Erythropoietin open a Novel Avenue for Periodontal Regeneration? Cureus. 2024;16(1):e52825. 10.7759/cureus.52825.38406126
19. Rolfing JH The effect of erythropoietin on bone Acta Orthop Suppl 2014 85 353 1 27 10.3109/17453674.2013.869716 24484318
Rolfing JH. The effect of erythropoietin on bone. Acta Orthop Suppl. 2014;85(353):1–27. 10.3109/17453674.2013.869716.24484318
20. Luo B Gan W Liu Z Shen Z Wang J Shi R Erythropoeitin Signaling in Macrophages promotes dying cell clearance and Immune Tolerance Immunity 2016 44 2 287 302 10.1016/j.immuni.2016.01.002 26872696
Luo B, Gan W, Liu Z, Shen Z, Wang J, Shi R, et al. Erythropoeitin Signaling in Macrophages promotes dying cell clearance and Immune Tolerance. Immunity. 2016;44(2):287–302. 10.1016/j.immuni.2016.01.002.26872696
21. Luo B Wang J Liu Z Shen Z Shi R Liu YQ Phagocyte respiratory burst activates macrophage erythropoietin signalling to promote acute inflammation resolution Nat Commun 2016 7 12177 10.1038/ncomms12177 27397585
Luo B, Wang J, Liu Z, Shen Z, Shi R, Liu YQ, et al. Phagocyte respiratory burst activates macrophage erythropoietin signalling to promote acute inflammation resolution. Nat Commun. 2016;7:12177. 10.1038/ncomms12177.27397585
22. Wang S Zhang C Li J Niyazi S Zheng L Xu M Erythropoietin protects against rhabdomyolysis-induced acute kidney injury by modulating macrophage polarization Cell Death Dis 2017 8 4 e2725 2725 10.1038/cddis.2017.104 28383559
Wang S, Zhang C, Li J, Niyazi S, Zheng L, Xu M, et al. Erythropoietin protects against rhabdomyolysis-induced acute kidney injury by modulating macrophage polarization. Cell Death Dis. 2017;8(4):e2725–2725. 10.1038/cddis.2017.104.28383559
23. Siebert N Xu W Grambow E Zechner D Vollmar B Erythropoietin improves skin wound healing and activates the TGF-beta signaling pathway Lab Invest 2011 91 12 1753 65 10.1038/labinvest.2011.125 21894148
Siebert N, Xu W, Grambow E, Zechner D, Vollmar B. Erythropoietin improves skin wound healing and activates the TGF-beta signaling pathway. Lab Invest. 2011;91(12):1753–65. 10.1038/labinvest.2011.125.21894148
24. Hamed S Ullmann Y Egozi D Daod E Hellou E Ashkar M Fibronectin potentiates topical erythropoietin-induced wound repair in diabetic mice J Invest Dermatol 2011 131 6 1365 74 10.1038/jid.2011.15 21326299
Hamed S, Ullmann Y, Egozi D, Daod E, Hellou E, Ashkar M, et al. Fibronectin potentiates topical erythropoietin-induced wound repair in diabetic mice. J Invest Dermatol. 2011;131(6):1365–74. 10.1038/jid.2011.15.21326299
25. Bader A Ebert S Giri S Kremer M Liu S Nerlich A Skin regeneration with conical and hair follicle structure of deep second-degree scalding injuries via combined expression of the EPO receptor and beta common receptor by local subcutaneous injection of nanosized rhEPO Int J Nanomed 2012 7 1227 37 10.2147/IJN.S28186
Bader A, Ebert S, Giri S, Kremer M, Liu S, Nerlich A, et al. Skin regeneration with conical and hair follicle structure of deep second-degree scalding injuries via combined expression of the EPO receptor and beta common receptor by local subcutaneous injection of nanosized rhEPO. Int J Nanomed. 2012;7:1227–37. 10.2147/IJN.S28186.
26. Javadmoosavi SY Parsamanesh N Afshar M Zardast M Ghaderi R Comparison of the effects of systemic and subcutaneous injection of recombinant human erythropoietin on the tissue-healing process in BALB/c mice J Surg Trauma 2020 8 1 16 22 10.32592/jsurgery.2020.8.1.102
Javadmoosavi SY, Parsamanesh N, Afshar M, Zardast M, Ghaderi R. Comparison of the effects of systemic and subcutaneous injection of recombinant human erythropoietin on the tissue-healing process in BALB/c mice. J Surg Trauma. 2020;8(1):16–22. 10.32592/jsurgery.2020.8.1.102.
27. Stoltz JF de Isla N Li YP Bensoussan D Zhang L Huselstein C Stem cells and Regenerative Medicine: myth or reality of the 21th century Stem Cells Int 2015 2015 734731 10.1155/2015/734731 26300923
Stoltz JF, de Isla N, Li YP, Bensoussan D, Zhang L, Huselstein C, et al. Stem cells and Regenerative Medicine: myth or reality of the 21th century. Stem Cells Int. 2015;2015:734731. 10.1155/2015/734731.26300923
28. Kallmeyer K André-Lévigne D Baquié M Krause KH Pepper MS Pittet-Cuénod B Fate of systemically and locally administered adipose-derived mesenchymal stromal cells and their effect on wound healing Stem Cells Transl Med 2020 9 1 131 44 10.1002/sctm.19-0091 31613054
Kallmeyer K, André-Lévigne D, Baquié M, Krause KH, Pepper MS, Pittet-Cuénod B, et al. Fate of systemically and locally administered adipose-derived mesenchymal stromal cells and their effect on wound healing. Stem Cells Transl Med. 2020;9(1):131–44. 10.1002/sctm.19-0091.31613054
29. Chalisserry EP Nam SY Park SH Anil S Therapeutic potential of dental stem cells J Tissue Eng 2017 8 2041731417702531 10.1177/2041731417702531 28616151
Chalisserry EP, Nam SY, Park SH, Anil S. Therapeutic potential of dental stem cells. J Tissue Eng. 2017;8:2041731417702531. 10.1177/2041731417702531.28616151
30. Eggenhofer E Benseler V Kroemer A Popp FC Geissler EK Schlitt HJ Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion Front Immunol 2012 3 297 10.3389/fimmu.2012.00297 23056000
Eggenhofer E, Benseler V, Kroemer A, Popp FC, Geissler EK, Schlitt HJ, et al. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front Immunol. 2012;3:297. 10.3389/fimmu.2012.00297.23056000
31. Konala VB Mamidi MK Bhonde R Das AK Pochampally R Pal R The current landscape of the mesenchymal stromal cell secretome: a new paradigm for cell-free regeneration Cytotherapy 2016 18 1 13 24 10.1016/j.jcyt.2015.10.008 26631828
Konala VB, Mamidi MK, Bhonde R, Das AK, Pochampally R, Pal R. The current landscape of the mesenchymal stromal cell secretome: a new paradigm for cell-free regeneration. Cytotherapy. 2016;18(1):13–24. 10.1016/j.jcyt.2015.10.008.26631828
32. Munoz-Perez E Gonzalez-Pujana A Igartua M Santos Vizcaíno E Hernandez R Mesenchymal stromal cell secretome for the treatment of Immune-mediated inflammatory diseases: latest trends in isolation, content optimization and delivery avenues Pharmaceutics 2021 13 1802 10.3390/pharmaceutics13111802 34834217
Munoz-Perez E, Gonzalez-Pujana A, Igartua M, Santos Vizcaíno E, Hernandez R. Mesenchymal stromal cell secretome for the treatment of Immune-mediated inflammatory diseases: latest trends in isolation, content optimization and delivery avenues. Pharmaceutics. 2021;13:1802. 10.3390/pharmaceutics13111802.34834217
33. Johnson SM, Banyard A, Smith C, Mironov A, McCabe MG. Large extracellular vesicles can be characterised by multiplex labelling using imaging Flow Cytometry. Int J Mol Sci. 2020;21(22). 10.3390/ijms21228723.
34. Moghadasi S Elveny M Rahman HS Suksatan W Jalil AT Abdelbasset WK A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine J Transl Med 2021 19 1 302 10.1186/s12967-021-02980-6 34253242
Moghadasi S, Elveny M, Rahman HS, Suksatan W, Jalil AT, Abdelbasset WK, et al. A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine. J Transl Med. 2021;19(1):302. 10.1186/s12967-021-02980-6.34253242
35. Trigo CM Rodrigues JS Camões SP Solá S Miranda JP Mesenchymal stem cell secretome for regenerative medicine: where do we stand? J Adv Res 2024 10.1016/j.jare.2024.05.004 38729561
Trigo CM, Rodrigues JS, Camões SP, Solá S, Miranda JP. Mesenchymal stem cell secretome for regenerative medicine: where do we stand? J Adv Res. 2024. 10.1016/j.jare.2024.05.004.38729561
36. Md Fadilah NI Mohd Abdul Kader Jailani MS Badrul Hisham MAI Sunthar Raj N Shamsuddin SA Ng MH Cell secretomes for wound healing and tissue regeneration: next generation acellular based tissue engineered products J Tissue Eng 2022 13 20417314221114273 10.1177/20417314221114273 35923177
Md Fadilah NI, Mohd Abdul Kader Jailani MS, Badrul Hisham MAI, Sunthar Raj N, Shamsuddin SA, Ng MH, et al. Cell secretomes for wound healing and tissue regeneration: next generation acellular based tissue engineered products. J Tissue Eng. 2022;13:20417314221114273. 10.1177/20417314221114273.35923177
37. Hany E Elkashty AAR El-Qashty R The regenerative potential of adipose-derived stem cells Versus their conditioned media on Tongue defects of adult male rats Egypt J Histol 2022 10.21608/EJH.2022.175334.1818
Hany E, Elkashty AAR, El-Qashty R. The regenerative potential of adipose-derived stem cells Versus their conditioned media on Tongue defects of adult male rats. Egypt J Histol. 2022. 10.21608/EJH.2022.175334.1818.
38. El-Qashty R Elkashty OA Hany E Photobiostimulation conjugated with stem cells or their secretome for temporomandibular joint arthritis in a rat model BMC Oral Health 2023 23 1 720 10.1186/s12903-023-03466-1 37798702
El-Qashty R, Elkashty OA, Hany E. Photobiostimulation conjugated with stem cells or their secretome for temporomandibular joint arthritis in a rat model. BMC Oral Health. 2023;23(1):720. 10.1186/s12903-023-03466-1.37798702
39. Giannasi C Della Morte E Cadelano F Valenza A Casati S Dei Cas M Boosting the therapeutic potential of cell secretome against osteoarthritis: comparison of cytokine-based priming strategies Biomed Pharmacother 2024 170 115970 10.1016/j.biopha.2023.115970 38042116
Giannasi C, Della Morte E, Cadelano F, Valenza A, Casati S, Dei Cas M, et al. Boosting the therapeutic potential of cell secretome against osteoarthritis: comparison of cytokine-based priming strategies. Biomed Pharmacother. 2024;170:115970. 10.1016/j.biopha.2023.115970.38042116
40. Kim WS Park BS Sung JH The wound-healing and antioxidant effects of adipose-derived stem cells Expert Opin Biol Ther 2009 9 7 879 87 10.1517/14712590903039684 19522555
Kim WS, Park BS, Sung JH. The wound-healing and antioxidant effects of adipose-derived stem cells. Expert Opin Biol Ther. 2009;9(7):879–87. 10.1517/14712590903039684.19522555
41. Hany E Elkashty AAR El-Qashty R The regenerative potential of adipose-derived stem cells versus their conditioned media on tongue defects of adult male rats Egypt J Histol 2024 47 1 253 67 10.21608/EJH.2022.175334.1818
Hany E, Elkashty AAR, El-Qashty R. The regenerative potential of adipose-derived stem cells versus their conditioned media on tongue defects of adult male rats. Egypt J Histol. 2024;47(1):253–67. 10.21608/EJH.2022.175334.1818.
42. Watanabe S Alexander M Misharin AV Budinger GRS The role of macrophages in the resolution of inflammation J Clin Invest 2019 129 7 2619 28 10.1172/JCI124615 31107246
Watanabe S, Alexander M, Misharin AV, Budinger GRS. The role of macrophages in the resolution of inflammation. J Clin Invest. 2019;129(7):2619–28. 10.1172/JCI124615.31107246
43. Ross EA Devitt A Johnson JR Macrophages The Good, the bad, and the Gluttony Front Immunol 2021 12 708186 10.3389/fimmu.2021.708186 34456917
Ross EA, Devitt A, Johnson JR, Macrophages. The Good, the bad, and the Gluttony. Front Immunol. 2021;12:708186. 10.3389/fimmu.2021.708186.34456917
44. Yilmaz M Demir E Firatli Y Firatli E Gursoy UK Tissue levels of CD80, CD163 and CD206 and their ratios in Periodontal and Peri-implant Health and Disease Curr Issues Mol Biol 2022 44 10 4704 13 10.3390/cimb44100321 36286036
Yilmaz M, Demir E, Firatli Y, Firatli E, Gursoy UK. Tissue levels of CD80, CD163 and CD206 and their ratios in Periodontal and Peri-implant Health and Disease. Curr Issues Mol Biol. 2022;44(10):4704–13. 10.3390/cimb44100321.36286036
45. Jablonski KA Amici SA Webb LM Ruiz-Rosado Jde D Popovich PG Partida-Sanchez S Novel markers to delineate murine M1 and M2 macrophages PLoS ONE 2015 10 12 e0145342 10.1371/journal.pone.0145342 26699615
Jablonski KA, Amici SA, Webb LM, Ruiz-Rosado Jde D, Popovich PG, Partida-Sanchez S, et al. Novel markers to delineate murine M1 and M2 macrophages. PLoS ONE. 2015;10(12):e0145342. 10.1371/journal.pone.0145342.26699615
46. McCormick-Ell J Connell N Laboratory Safety, Biosecurity, and responsible animal Use ILAR J 2019 60 1 24 33 10.1093/ilar/ilz012 31423527
McCormick-Ell J, Connell N. Laboratory Safety, Biosecurity, and responsible animal Use. ILAR J. 2019;60(1):24–33. 10.1093/ilar/ilz012.31423527
47. Xu X Gu Z Chen X Shi C Liu C Liu M An injectable and thermosensitive hydrogel: promoting periodontal regeneration by controlled-release of aspirin and erythropoietin Acta Biomater 2019 86 235 46 10.1016/j.actbio.2019.01.001 30611793
Xu X, Gu Z, Chen X, Shi C, Liu C, Liu M, et al. An injectable and thermosensitive hydrogel: promoting periodontal regeneration by controlled-release of aspirin and erythropoietin. Acta Biomater. 2019;86:235–46. 10.1016/j.actbio.2019.01.001.30611793
48. Hany E Yahia S Elsherbeny MF Salama NM Ateia IM Abou El-Khier NT Evaluation of the osteogenic potential of rat adipose-derived stem cells with different polycaprolactone/alginate-based nanofibrous scaffolds: an in vitro study Stem Cell Investig 2020 7 14 10.21037/sci-2020-015 32964007
Hany E, Yahia S, Elsherbeny MF, Salama NM, Ateia IM, Abou El-Khier NT, et al. Evaluation of the osteogenic potential of rat adipose-derived stem cells with different polycaprolactone/alginate-based nanofibrous scaffolds: an in vitro study. Stem Cell Investig. 2020;7:14. 10.21037/sci-2020-015.32964007
49. Ahn S Min SK Min SI Suh JH Kim SJ Ha J Early sustained injections of erythropoietin improve angiogenesis and restoration of perfusion in the ischemic mouse hindlimb J Korean Med Sci 2012 27 9 1073 8 10.3346/jkms.2012.27.9.1073 22969255
Ahn S, Min SK, Min SI, Suh JH, Kim SJ, Ha J. Early sustained injections of erythropoietin improve angiogenesis and restoration of perfusion in the ischemic mouse hindlimb. J Korean Med Sci. 2012;27(9):1073–8. 10.3346/jkms.2012.27.9.1073.22969255
50. Baykal M Gökmen N Doğan A Erbayraktar S Yılmaz O Ocmen E The effects of intra-cerebroventricular administered rocuronium on the central nervous system of rats and determination of its epileptic seizure-inducing dose Revista brasileira de anestesiologia 2017 67 1 1 5 10.1016/j.bjane.2015.02.010 27855944
Baykal M, Gökmen N, Doğan A, Erbayraktar S, Yılmaz O, Ocmen E, et al. The effects of intra-cerebroventricular administered rocuronium on the central nervous system of rats and determination of its epileptic seizure-inducing dose. Revista brasileira de anestesiologia. 2017;67(1):1–5. 10.1016/j.bjane.2015.02.010.27855944
51. MacDonald AF Gross AJ Jones BJ Dhar MS Muscle regeneration of the Tongue: a review of current clinical and regenerative research strategies Tissue Eng Part B Rev 2022 28 5 1022 34 10.1089/ten.TEB.2021.0133 34693743
MacDonald AF, Gross AJ, Jones BJ, Dhar MS. Muscle regeneration of the Tongue: a review of current clinical and regenerative research strategies. Tissue Eng Part B Rev. 2022;28(5):1022–34. 10.1089/ten.TEB.2021.0133.34693743
52. Inchingolo F Santacroce L Ballini A Topi S Dipalma G Haxhirexha K Oral cancer: a historical review Int J Environ Res Public Health 2020 17 9 3168 10.3390/ijerph17093168 32370133
Inchingolo F, Santacroce L, Ballini A, Topi S, Dipalma G, Haxhirexha K, et al. Oral cancer: a historical review. Int J Environ Res Public Health. 2020;17(9):3168. 10.3390/ijerph17093168.32370133
53. Lee G Chang YJ Park J Ryu JY Choi KY Yang JD Free Vertical Latissimus Dorsi flap for Tongue Reconstruction after total glossectomy Vivo 2023 37 6 2710 8 10.21873/invivo.13381
Lee G, Chang YJ, Park J, Ryu JY, Choi KY, Yang JD, et al. Free Vertical Latissimus Dorsi flap for Tongue Reconstruction after total glossectomy. Vivo. 2023;37(6):2710–8. 10.21873/invivo.13381.
54. Almarza AJ Hagandora CK Henderson SE Animal models of temporomandibular joint disorders: implications for tissue engineering approaches Ann Biomed Eng 2011 39 10 2479 90 10.1007/s10439-011-0364-8 21822741
Almarza AJ, Hagandora CK, Henderson SE. Animal models of temporomandibular joint disorders: implications for tissue engineering approaches. Ann Biomed Eng. 2011;39(10):2479–90. 10.1007/s10439-011-0364-8.21822741
55. Jasper J, Roithmann S, Camilotti RS, Salum FG, Cherubini K, Zancanaro de Figueiredo MA. Effect of G-CSF on oral mucositis and traumatic ulcers produced in the tongue of rats undergoing radiotherapy: clinical and histologic evaluation. Oral surgery, oral medicine, oral pathology and oral radiology. 2016;122(5):587–96. 10.1016/j.oooo.2016.07.021
56. Nguyen CT Kim CR Le TH Koo KI Hwang CH Magnetically guided targeted delivery of erythropoietin using magnetic nanoparticles: Proof of concept Medicine 2020 99 19 e19972 10.1097/md.0000000000019972 32384447
Nguyen CT, Kim CR, Le TH, Koo KI, Hwang CH. Magnetically guided targeted delivery of erythropoietin using magnetic nanoparticles: Proof of concept. Medicine. 2020;99(19):e19972. 10.1097/md.0000000000019972.32384447
57. Bulmer C Margaritis A Xenocostas A Production and characterization of novel chitosan nanoparticles for controlled release of rHu-Erythropoietin Biochem Eng J 2012 68 61 9 10.1016/j.bej.2012.07.007
Bulmer C, Margaritis A, Xenocostas A. Production and characterization of novel chitosan nanoparticles for controlled release of rHu-Erythropoietin. Biochem Eng J. 2012;68:61–9. 10.1016/j.bej.2012.07.007.
58. Yue H Wei W Yue Z Lv P Wang L Ma G Particle size affects the cellular response in macrophages Eur J Pharm Sci 2010 41 5 650 7 10.1016/j.ejps.2010.09.006 20870022
Yue H, Wei W, Yue Z, Lv P, Wang L, Ma G, et al. Particle size affects the cellular response in macrophages. Eur J Pharm Sci. 2010;41(5):650–7. 10.1016/j.ejps.2010.09.006.20870022
59. Rezazadeh M Akbari V Varshosaz J Karbasizadeh P Minaiyan M Sustained-release of erythropoietin using a novel injectable thermosensitive hydrogel: in vitro studies, biological activity, and efficacy in rats Pharm Dev Technol 2021 26 4 412 21 10.1080/10837450.2021.1883059 33538616
Rezazadeh M, Akbari V, Varshosaz J, Karbasizadeh P, Minaiyan M. Sustained-release of erythropoietin using a novel injectable thermosensitive hydrogel: in vitro studies, biological activity, and efficacy in rats. Pharm Dev Technol. 2021;26(4):412–21. 10.1080/10837450.2021.1883059.33538616
60. Yassin AE Albekairy AM Omer ME Almutairi A Alotaibi Y Althuwaini S Chitosan-Coated Azithromycin/Ciprofloxacin-Loaded polycaprolactone nanoparticles: a characterization and potency study Nanatechnol Sci Appl 2023 16 59 72 10.2147/nsa.S438484
Yassin AE, Albekairy AM, Omer ME, Almutairi A, Alotaibi Y, Althuwaini S, et al. Chitosan-Coated Azithromycin/Ciprofloxacin-Loaded polycaprolactone nanoparticles: a characterization and potency study. Nanatechnol Sci Appl. 2023;16:59–72. 10.2147/nsa.S438484.
61. Kumar A, Dixit CK. 3 - methods for characterization of nanoparticles. In: Nimesh S, Chandra R, Gupta N, editors. Advances in Nanomedicine for the delivery of therapeutic nucleic acids. Woodhead Publishing; 2017. pp. 43–58.
62. Xu Q Shanti RM Zhang Q Cannady SB O’Malley BW Jr Le ADA Gingiva-Derived Mesenchymal stem cell-Laden Porcine Small Intestinal Submucosa Extracellular Matrix Construct promotes myomucosal regeneration of the Tongue Tissue Eng Part A 2017 23 7–8 301 12 10.1089/ten.TEA.2016.0342 27923325
Xu Q, Shanti RM, Zhang Q, Cannady SB, O’Malley BW Jr., Le ADA, Gingiva-Derived. Mesenchymal stem cell-Laden Porcine Small Intestinal Submucosa Extracellular Matrix Construct promotes myomucosal regeneration of the Tongue. Tissue Eng Part A. 2017;23(7–8):301–12. 10.1089/ten.TEA.2016.0342.27923325
63. Toma AI Fuller JM Willett NJ Goudy SL Oral wound healing models and emerging regenerative therapies Translational Res 2021 236 17 34 10.1016/j.trsl.2021.06.003
Toma AI, Fuller JM, Willett NJ, Goudy SL. Oral wound healing models and emerging regenerative therapies. Translational Res. 2021;236:17–34. 10.1016/j.trsl.2021.06.003.
64. Gu Z Qiu C Chen L Wang X Injectable thermosensitive hydrogel loading erythropoietin and FK506 alleviates gingival inflammation and promotes periodontal tissue regeneration Front Bioeng Biotechnol 2023 11 1323554 10.3389/fbioe.2023.1323554 38239915
Gu Z, Qiu C, Chen L, Wang X. Injectable thermosensitive hydrogel loading erythropoietin and FK506 alleviates gingival inflammation and promotes periodontal tissue regeneration. Front Bioeng Biotechnol. 2023;11:1323554. 10.3389/fbioe.2023.1323554.38239915
65. Rezazadeh M Jafari N Akbari V Amirian M Tabbakhian M Minaiyan M A mucoadhesive thermosensitive hydrogel containing erythropoietin as a potential treatment in oral mucositis: in vitro and in vivo studies Drug Deliv Transl Res 2018 8 5 1226 37 10.1007/s13346-018-0566-9 30076521
Rezazadeh M, Jafari N, Akbari V, Amirian M, Tabbakhian M, Minaiyan M, et al. A mucoadhesive thermosensitive hydrogel containing erythropoietin as a potential treatment in oral mucositis: in vitro and in vivo studies. Drug Deliv Transl Res. 2018;8(5):1226–37. 10.1007/s13346-018-0566-9.30076521
66. Shao J Nie P Yang W Guo R Ding D Liang R An EPO-loaded multifunctional hydrogel synergizing with adipose-derived stem cells restores neurogenic erectile function via enhancing nerve regeneration and penile rehabilitation Bioeng Transl Med 2022 7 3 e10319 10.1002/btm2.10319 36176612
Shao J, Nie P, Yang W, Guo R, Ding D, Liang R, et al. An EPO-loaded multifunctional hydrogel synergizing with adipose-derived stem cells restores neurogenic erectile function via enhancing nerve regeneration and penile rehabilitation. Bioeng Transl Med. 2022;7(3):e10319. 10.1002/btm2.10319.36176612
67. Li D Zhao L Cong M Liu L Yan G Li Z Injectable thermosensitive chitosan/gelatin-based hydrogel carried erythropoietin to effectively enhance maxillary sinus floor augmentation in vivo Dent Mater 2020 36 7 e229 40 10.1016/j.dental.2020.04.016 32471559
Li D, Zhao L, Cong M, Liu L, Yan G, Li Z, et al. Injectable thermosensitive chitosan/gelatin-based hydrogel carried erythropoietin to effectively enhance maxillary sinus floor augmentation in vivo. Dent Mater. 2020;36(7):e229–40. 10.1016/j.dental.2020.04.016.32471559
68. Bronckaers A Hilkens P Martens W Gervois P Ratajczak J Struys T Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis Pharmacol Ther 2014 143 2 181 96 10.1016/j.pharmthera.2014.02.013 24594234
Bronckaers A, Hilkens P, Martens W, Gervois P, Ratajczak J, Struys T, et al. Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis. Pharmacol Ther. 2014;143(2):181–96. 10.1016/j.pharmthera.2014.02.013.24594234
69. Jaheen MZ Sholqamy MIA Sharfeldeen AERM Amar SGK Regenerative capability of bone marrow stem cells-derived Secretome for treating traumatic oral ulcers in albino rats (Immunohistomorphometric Study) Ain Shams Dent J 2024 34 2 109 19 10.21608/asdj.2024.285158.1261
Jaheen MZ, Sholqamy MIA, Sharfeldeen AERM, Amar SGK. Regenerative capability of bone marrow stem cells-derived Secretome for treating traumatic oral ulcers in albino rats (Immunohistomorphometric Study). Ain Shams Dent J. 2024;34(2):109–19. 10.21608/asdj.2024.285158.1261.
70. Gao M Zhang J Wang J Liu Y Zhang X Shi Y Effects of hypoxia-pretreated rat adipose-derived mesenchymal stem cells conditioned medium on wound healing of rats with full-thickness defects Chin J Burns 2020 36 9 803 12 10.3760/cma.j.cn501120-20200508-00258
Gao M, Zhang J, Wang J, Liu Y, Zhang X, Shi Y. Effects of hypoxia-pretreated rat adipose-derived mesenchymal stem cells conditioned medium on wound healing of rats with full-thickness defects. Chin J Burns. 2020;36(9):803–12. 10.3760/cma.j.cn501120-20200508-00258.
71. Li L, Ngo HTT, Hwang E, Wei X, Liu Y, Liu J, et al. Conditioned medium from human adipose-derived mesenchymal stem Cell Culture prevents UVB-Induced skin aging in human keratinocytes and dermal fibroblasts. Int J Mol Sci. 2019;21(1). 10.3390/ijms21010049.
72. Spees JL Lee RH Gregory CA Mechanisms of mesenchymal stem/stromal cell function Stem Cell Res Ther 2016 7 1 125 10.1186/s13287-016-0363-7 27581859
Spees JL, Lee RH, Gregory CA. Mechanisms of mesenchymal stem/stromal cell function. Stem Cell Res Ther. 2016;7(1):125. 10.1186/s13287-016-0363-7.27581859
73. Coulange Zavarro A, Velier M, Arcani R, Abellan Lopez M, Simoncini S, Benyamine A, et al. Adipose tissue and adipose-tissue-derived cell therapies for the treatment of the Face and hands of patients suffering from systemic sclerosis. Biomedicines. 2023;11(2). 10.3390/biomedicines11020348.
74. Chicharro D Carrillo JM Rubio M Cugat R Cuervo B Guil S Combined plasma rich in growth factors and adipose-derived mesenchymal stem cells promotes the cutaneous wound healing in rabbits BMC Vet Res 2018 14 1 288 10.1186/s12917-018-1577-y 30241533
Chicharro D, Carrillo JM, Rubio M, Cugat R, Cuervo B, Guil S, et al. Combined plasma rich in growth factors and adipose-derived mesenchymal stem cells promotes the cutaneous wound healing in rabbits. BMC Vet Res. 2018;14(1):288. 10.1186/s12917-018-1577-y.30241533
75. Zhang Y Shi S Xu Q Zhang Q Shanti RM Le AD SIS-ECM Laden with GMSC-Derived exosomes promote taste Bud Regeneration J Dent Res 2019 98 2 225 33 10.1177/0022034518804531 30335555
Zhang Y, Shi S, Xu Q, Zhang Q, Shanti RM, Le AD. SIS-ECM Laden with GMSC-Derived exosomes promote taste Bud Regeneration. J Dent Res. 2019;98(2):225–33. 10.1177/0022034518804531.30335555
76. Nielsen MC Hvidbjerg Gantzel R Claria J Trebicka J Moller HJ Gronbaek H Macrophage activation markers, CD163 and CD206, in Acute-on-chronic liver failure Cells 2020 9 5 1175 10.3390/cells9051175 32397365
Nielsen MC, Hvidbjerg Gantzel R, Claria J, Trebicka J, Moller HJ, Gronbaek H. Macrophage activation markers, CD163 and CD206, in Acute-on-chronic liver failure. Cells. 2020;9(5):1175. 10.3390/cells9051175.32397365
77. Hu JM Liu K Liu JH Jiang XL Wang XL Chen YZ CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma Oncotarget 2017 8 13 21526 38 10.18632/oncotarget.15630 28423526
Hu JM, Liu K, Liu JH, Jiang XL, Wang XL, Chen YZ, et al. CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma. Oncotarget. 2017;8(13):21526–38. 10.18632/oncotarget.15630.28423526
78. Kwiecień I Polubiec-Kownacka M Dziedzic D Wołosz D Rzepecki P Domagała-Kulawik J CD163 and CCR7 as markers for macrophage polarization in lung cancer microenvironment Cent Eur J Immunol 2019 44 4 395 402 10.5114/ceji.2019.92795 32140052
Kwiecień I, Polubiec-Kownacka M, Dziedzic D, Wołosz D, Rzepecki P, Domagała-Kulawik J. CD163 and CCR7 as markers for macrophage polarization in lung cancer microenvironment. Cent Eur J Immunol. 2019;44(4):395–402. 10.5114/ceji.2019.92795.32140052
79. Skytthe MK Graversen JH Moestrup SK Targeting of CD163 + macrophages in Inflammatory and Malignant diseases Int J Mol Sci 2020 21 15 5497 10.3390/ijms21155497 32752088
Skytthe MK, Graversen JH, Moestrup SK. Targeting of CD163 + macrophages in Inflammatory and Malignant diseases. Int J Mol Sci. 2020;21(15):5497. 10.3390/ijms21155497.32752088
80. Li Y Peng H Tang W Gu D Ren S Yu Y Accelerating periodontal regeneration through injectable hydrogel-enabled sequential delivery of nanoceria and erythropoietin Mater Design 2023 225 111540 10.1016/j.matdes.2022.111540
Li Y, Peng H, Tang W, Gu D, Ren S, Yu Y, et al. Accelerating periodontal regeneration through injectable hydrogel-enabled sequential delivery of nanoceria and erythropoietin. Mater Design. 2023;225:111540. 10.1016/j.matdes.2022.111540.
81. Kruger MJ Conradie MM Conradie M van de Vyver M ADSC-conditioned media elicit an ex vivo anti-inflammatory macrophage response J Mol Endocrinol 2018 61 4 173 84 10.1530/JME-18-0078 30038054
Kruger MJ, Conradie MM, Conradie M, van de Vyver M. ADSC-conditioned media elicit an ex vivo anti-inflammatory macrophage response. J Mol Endocrinol. 2018;61(4):173–84. 10.1530/JME-18-0078.30038054
82. Li R Li D Wang H Chen K Wang S Xu J Exosomes from adipose-derived stem cells regulate M1/M2 macrophage phenotypic polarization to promote bone healing via miR-451a/MIF Stem Cell Res Ther 2022 13 1 149 10.1186/s13287-022-02823-1 35395782
Li R, Li D, Wang H, Chen K, Wang S, Xu J, et al. Exosomes from adipose-derived stem cells regulate M1/M2 macrophage phenotypic polarization to promote bone healing via miR-451a/MIF. Stem Cell Res Ther. 2022;13(1):149. 10.1186/s13287-022-02823-1.35395782
83. Arslantaş MK Arslantaş R Tozan EN Effects of systemic erythropoietin on ischemic wound healing in rats Ostomy Wound Manag 2015 61 3 28 33
Arslantaş MK, Arslantaş R, Tozan EN. Effects of systemic erythropoietin on ischemic wound healing in rats. Ostomy Wound Manag. 2015;61(3):28–33.
84. Conforti A Scarsella M Starc N Giorda E Biagini S Proia A Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro Stem Cells Dev 2014 23 21 2591 9 10.1089/scd.2014.0091 24937591
Conforti A, Scarsella M, Starc N, Giorda E, Biagini S, Proia A, et al. Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro. Stem Cells Dev. 2014;23(21):2591–9. 10.1089/scd.2014.0091.24937591
85. Gabr H Helal O Mohamed H Abo Elkheir W El-Bedawy S Abo Elkheir A Comparison between mesenchymal stem cells, stem cell conditioned media, and mesenchymal stem cell derived microsvesicles in regeneration in murine model of acute renal injury Cytotherapy 2017 19 5, Supplement S25 10.1016/j.jcyt.2017.02.046
Gabr H, Helal O, Mohamed H, Abo Elkheir W, El-Bedawy S, Abo Elkheir A. Comparison between mesenchymal stem cells, stem cell conditioned media, and mesenchymal stem cell derived microsvesicles in regeneration in murine model of acute renal injury. Cytotherapy. 2017;19(5, Supplement):S25. 10.1016/j.jcyt.2017.02.046.
